KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Income Statement
NASDAQ:KZIA - Nasdaq - US48669G3039 - ADR - Currency: USD
| 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.32M | 22.60K | 2.10K | 15.22M | 65.90K | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 29.51M | 24.15M | 25.38M | 21.56M | 12.20M | |||
| Research and Development | 15.51M | 15.56M | 20.17M | 14.54M | 9.49M | |||
| Selling, General, and Administrative Expenses | 13.56M | 8.58M | 5.23M | 7.02M | 3.69M | |||
| Operating Income | -27.19M | -24.12M | -25.38M | -6.34M | -12.13M | |||
| Interest Income/Expense | N/A | N/A | N/A | 0.00 | -163.20K | |||
| Other Income/Expense | 0.00 | 600.00 | 0.00 | 2.20K | 2.30K | |||
| Non Recurring Items | 144.00K | 3.39M | 0.00 | -2.57M | -474.60K | |||
| Income Before Taxes | -27.05M | -20.74M | -25.38M | -8.91M | -12.77M | |||
| Income Tax | -271.00K | -271.10K | -368.10K | -484.40K | -298.20K | |||
| Net Income | -26.78M | -20.47M | -25.01M | -8.42M | -12.47M | |||
| EBITDA | N/A | N/A | N/A | N/A | -11.05M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.23 | -57.14 | -97.16 | -36.74 | -84.07 | |||
| Statistics | ||||||||
| Profit Margin | -1154.22% | -90553.98% | -1191147.62% | -55.32% | -18918.82% | |||
| Operating Profit Margin | -1172.11% | -106745.58% | -1208671.43% | -41.63% | -18406.98% | |||
All data in AUD